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Abstract Conjugates between anti-tetanus F(abP)2 fragments
and the (37^72) fragment of the HIV Tat protein were taken up
by chromaffin cells, NG108-15 neurohybridoma cells and Rev-2-
T-6 lymphoma cells. The uptake could not be inhibited by
competition with (37^72)Tat, but was reduced in the presence of
metabolic inhibitors or at low temperature. The disulfide as well
as the thioether conjugate were translocated to the cytoplasmic
space, but only the disulfide conjugate moderately restored the
stimulated transmitter release inhibited by tetanus toxin. There-
fore, disulfide conjugates are more promising than thioethers for
the neutralization of intracellular antigens. These conjugates
provide new tools to study neuroprotection against bacterial
neurotoxins.
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1. Introduction
Tetanus toxin (TET), after being taken up by nerve cells
[1,2], hydrolyzes synaptobrevin by the enzymatic action of its
light chain [3,4]. As a consequence, stimulated exocytotic
transmitter release is reduced and may be entirely abolished
[5,6]. In vertebrates, inhibitory neurons in the spinal cord are
the ¢rst to be a¡ected [7]. The ensuing preponderance of ex-
citatory neuronal activity leads to spasms of the skeletal mus-
culature and later on to convulsions [8]. The recovery is very
slow. Patients require arti¢cial respiration for about 3 weeks
[9]. In chroma⁄n cells, 7 days after TET intoxication, the
inhibition of transmitter release shows no signi¢cant reversal
[10]. This long action of TET could be due to its very slow
degradation in nerve cells [10], so that the TET enzymatic
activity continues to hydrolyze the newly synthesized synapto-
brevin. Therefore, inactivation of intraneuronal TET with a
TET-neutralizing antibody should protect neuronal synapto-
brevin from degradation. Indeed, 3 days after introduction of
anti-TET antibodies by electroporation into TET-intoxicated
chroma⁄n cells their transmitter release was largely restored
[10,14]. Anti-TET antibodies outside neurons had no such
e¡ect [11^13], because antibodies cannot pass through the
neuronal plasma membrane.
Since electroporation cannot be used in a clinical situation
for the delivery of antibodies, we synthesized conjugates be-
tween anti-TET antibodies and peptides that are known to be
taken up by cells. In this report, results obtained with con-
jugates of anti-tetanus F(abP)2 fragments and the (37^72) frag-
ment of the HIV Tat protein are presented. The latter frag-
ment is taken up by cells [15] like the parent (1^86)Tat [16^
18], but is easier to synthesize and contains a single Cys (res-
idue 37) for a selective coupling to other molecules via thiol
chemistry. Our results show that a thioether as well as a
disul¢de conjugate of (37^72)Tat and anti-TET F(abP)2 were
taken up by the cells, but only the disul¢de conjugate neutral-
ized intracellular TET.
2. Materials and methods
Na125I was obtained from Amersham (Little Chalfont, UK); levo-
[ring 2,4,6-3H]norepinephrine was from NEN, 2-iminothiolane (ITH),
bis-maleimidohexane (BMH), sulfosuccinimidyl-6-[3P-(2-pyridyldi-
thio)propionamido]-hexanoate (slcSPDP), succinimidyl-4-(N-maleimi-
do-methyl)-cyclohexane-1-carboxylate (SMCC), its sulfosuccinimidyl
derivative (sSMCC) and Iodogen were purchased from Pierce (Rock-
ford, IL, USA); the £uorophores monosuccinimidyl Cy3 and Cy3.5
were from Molecular Probes (Eugene, OR, USA); all other reagents,
solvents and the culture media were of the highest quality available.
2.1. Synthesis of (37^72)Tat
The (37^72)Tat fragment was synthesized on a 433A peptide syn-
thesizer (Applied Biosystems, Foster City, CA, USA) using Fmoc
chemistry, and puri¢ed as described previously [19]. Purity and mo-
lecular weight of the product were determined by HPLC and electro-
spray mass spectrometry, respectively.
2.2. Anti-TET antibodies and their labeling
Anti-TET F(abP)2 fragments (nominal 5000 U/ml) were from Behr-
ing-Werke (Marburg, Germany). They belong to the batch used by
Bartels and Bigalke [10]. The total F(abP)2 concentration as deter-
mined with the Sigma BCA assay was 3U1033 M. The source solu-
tion was puri¢ed and adjusted to pH 7.0 or pH 8.0 using phosphate
bu¡er or borate bu¡er, respectively, by spin ¢ltration through Sepha-
dex G25F. Two samples were labeled with 125I by oxidative iodina-
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tion, using 37 MBq (1 mCi) Na125I and Iodogen. Several samples were
labeled with Cy3 or Cy3.5, following the supplier’s instructions but
using one vial of monosuccinimidyl Cy per 3^6 mg instead of 1 mg of
F(abP)2. The labeled fragments were dialyzed against borate bu¡er
(pH 8.5) before use.
2.3. Synthesis of 125I-F(abP)2-(37^72)Tat using SMCC
65 Wl of SMCC (1032 M in dimethylsulfoxide) was added to 250 Wl
of 125I-F(abP)2 (5.2U1035 M) in borate bu¡er (pH 8.5). After 2 h the
reaction mixture was centrifuged through Sephadex G25F/phosphate
bu¡er (pH 7.5). The educt MCC-125I-F(abP)2 was dialyzed against
borate bu¡er (pH 8.5). The protein concentration was 2.88U1035
M, and the MCC/F(abP)2 ratio was 2:1. 3.57U1038 mol of (37^
72)Tat in 35 Wl PBS (pH 7.0) was added to 310 Wl of this solution.
After another 12 h incubation at room temperature, the resulting
thioether conjugate was dialyzed against PBS (pH 7.0).
2.4. Synthesis of F(abP)2-(37^72)Tat and Cy3.5-F(abP)2-(37^72)Tat
using ITH and BMH
2U1032 M ITH in borate bu¡er (pH 8.5) was added to 2U1034 M
F(abP)2 in borate (pH 8.5) to obtain a 4^5-fold molar excess over the
protein concentration. After 2 h incubation at room temperature, the
reaction mixture was centrifuged through Sephadex G25F/borate
bu¡er (pH 8.5). A sample was diluted with PBS (pH 7.4), and the
thiol concentration was determined with Ellman’s reagent. Thiol/
F(abP)2 ratios of about 1.7 were obtained. The thiolated F(abP)2
was reacted with BMH at a 10-fold molar excess over the thiol con-
centration at room temperature for 1 h. The reaction mixture was
centrifuged through Sephadex G25F/borate bu¡er (pH 8.5), and
(37^72)Tat was added until a 3^4-fold molar excess over the thiol
concentration was obtained. After another incubation of 12 h at
room temperature, the thioether conjugate in the reaction mixture
was puri¢ed by dialysis against PBS (pH 7.4). The extinction coe⁄-
cients at 581 nm and 280 nm were measured to calculate the concen-
tration of Cy3.5 and protein, respectively. The 280 nm extinction was
corrected for the Cy3.5 contribution.
2.5. Synthesis of F(abP)2-(37^72)Tat and Cy3-F(abP)2-(37^72)Tat
with slcSPDP
Solid slcSPDP was added to 0.8^1.5U1033 M F(abP)2 in borate
bu¡er (pH 8.5), to obtain a 3^6-fold molar excess over the protein
concentration. Three hours were allowed for the acylation. The reac-
tion product F(abP)2-PDP was puri¢ed by dialysis against PBS (pH
7.0). The PDP concentration was determined by incubating a sample
with an excess of DTT and measuring the thiopyridon extinction at
343 nm. The 280 nm extinction, corrected for the contribution by
PDP and the £uorophores, was used to calculate the protein concen-
tration. (37^72)Tat was added to obtain a 3-fold molar excess over the
PDP concentration. At least 36 h were allowed for the thiol-disul¢de
exchange reaction. The resulting solution was puri¢ed by dialysis
against PBS (pH 7.0). The Cy3 and protein concentrations were de-
termined from the 280 nm and 552 nm extinctions, taking into ac-
count the 280 nm absorption of Cy3. The non-£uorescent conjugates
and the £uorescent thioether conjugates were stable at 4‡C for
3 weeks. The £uorescent disul¢de conjugate had to be used within
2 days, thereafter it became turbid.
2.6. Cell cultures
Bovine chroma⁄n cells were prepared according to an established
procedure [13]. They were plated on collagen-coated Petri dishes, al-
lowed 1 day to recover from preparation stress, and were then har-
vested for experiments. For laser confocal microscopy, they were
plated on collagen-coated cover glasses at a density of 105 cells/200
mm2. For electroporation, they were suspended at a density of 5U106
cells/ml in DMEM containing TET (1 or 2 nM).
Rev-2-T-6 cells, derived from S-49 mouse lymphoma cells, and
NG108-15 neurohybridoma cells were maintained as previously de-
scribed [20,21].
2.7. Uptake of 125I-F(abP)2-(37^72)Tat thioether
Rev-2-T-6 cells were suspended in uptake bu¡er (106 mM NaCl,
5 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 0.9 mM NaH2PO4,
25 mM HEPES, 25 mM glucose, 0.1% BSA, pH 7.4) to a density
of 106 cells/ml. 125I-labeled conjugates or 125I-F(abP)2 were added to
0.5 ml triplicates of this suspension to obtain ¢nal concentrations
between 1039 M and 3.16U1038 M. The cells were incubated for
1 h, then washed three times with cold (4‡C) uptake bu¡er. The
radioactivity of the cell pellets was counted, and the protein concen-
tration of the SDS-solubilized pellets was determined using the Sigma
BCA assay.
NG108-15 cells were suspended at a density of 0.5^1.0U106 cells/ml
in uptake bu¡er (NaCl 109 mM, KCl 5.4 mM, CaCl2 1.2 mM, MgCl2
0.4 mM, NaH2PO4 0.9 mM, HEPES 12.5 mM, glucose 25 mM, 0.1%
BSA, pH 7.4). In the experiments with metabolic inhibitors, glucose
and NaCl were isotonically replaced with 25 mM deoxy-D-glucose,
10 mM NaCN and 10 mM NaN3. The cells were incubated with
125I-F(abP)2-(37^72)Tat thioether conjugate at concentrations of 1,
3.2, 10, and 32 nM, and at the following conditions: at 37‡C, at
37‡C in the presence of metabolic inhibitors, at 37‡C in the presence
of non-labeled (37^72)Tat, and at 4‡C.
2.8. Confocal microscopy
Chroma⁄n cells were incubated for 16 h with conjugates or control
substances. They were then washed twice with PBS (pH 7.0), ¢xed
with 4% bu¡ered formaldehyde for 30 min, again washed twice with
PBS, covered with glycerol and stored at 4‡C. The confocal micro-
scope setup was described earlier [22]. The data presented in this
report were obtained using 514 nm excitation, while the emission ¢lter
was a 580DF32 (580 þ 16 nm) interference ¢lter. Control experiments
with unstained cells showed that auto£uorescence was undetectable at
the ¢lter and gain settings which were used to record the data. Optical
sections were acquired at a spacing of about 0.3 Wm. The images were
¢ltered with a 3U3 median ¢lter, and the black level was subtracted.
2.9. Stimulated exocytotic 3H release
Bovine chroma⁄n cells were electroporated using the method of
Bartels and Bigalke [10]. The electroporated cells were plated on 24
well plates (about 2U105 cells per collagen-coated well). Two days
later, the medium was replaced with DMEM containing either the
conjugates (27, 81, or 243 nM) or non-conjugated F(abP)2 (243
nM). After another 2 days, these media were exchanged for fresh
DMEM. The exocytosis experiments were done 3 days after the ap-
plication of the conjugates. The method described by Bartels and
Bigalke [10] was applied with some modi¢cations. Brie£y,
[3H]norepinephrine was diluted with equilibrated DMEM to 4.4
kBq (120 nCi)/ml, and chroma⁄n cells plated into the collagen-coated
wells of 24 well plates were incubated with 250 Wl of this solution at
37‡C for 2 h. The solution was replaced with fresh DMEM, and
another hour at 37‡C was allowed for incorporation of surface-bound
radioactivity. The cells were then washed three times with release
bu¡er (125.6 mM NaCl, 4.8 mM KCl, 2.2 mM CaCl2, 1.2 mM
MgSO4, 1.2 mM KH2PO4, 5.6 mM glucose, 25 mM HEPES, 1 mM
sodium ascorbate, 0.2% BSA, pH 7.3). During the next 8 min, the
basal release into 450 Wl/well of the same bu¡er was determined. The
bu¡er was exchanged against 450 Wl/well of release bu¡er containing
5U1034 M carbachol. The stimulated 3H release was collected for
8 min. Finally, the cell pellet was suspended in 0.2% SDS. The 3H
basal release B, the 3H stimulated release S, and the 3H remaining in
the pellet R were counted. The results are given as fractional 3H
release F = 1000U(S3B)/(B+S+R).
2.10. Other methods
For the determination of concentrations by spectrophotometry, the
following extinction coe⁄cients were used: E[F(abP)2 1035 M in bo-
rate bu¡er (pH 8.5, 1 cm, 280 nm) = 0.977, E[Cy3 1035 M, 1 cm, 552
nm] = 1.3, E[Cy3.5 1035 M, 1 cm, 581 nm] = 1.5, E[pyridyl-2-thion
1035 M, 1 cm, 343 nm] = 0.0808, thiol groups with Ellman’s reagent
E[chromophore 1035 M, 1 cm, 420 nm] = 0.136. The 280 nm extinc-
tion contributed by the £uorophores and by PDP was calculated as
follows: E[Cy3, 280 nm] = 0.05UE[Cy3, 552 nm], E[Cy3.5, 280
nm] = 0.24UE[Cy3.5, 581 nm], E[PDP, 280 nm) = 0.63UE[pyridyl-2-
thion, 343 nm]. The protein concentration was also determined with
the Sigma BCA assay.
2.11. Statistical treatment
A di¡erence between the means of two data samples was tested for
signi¢cance using the t-test. Multiple di¡erences were tested after one-
way analysis of variance with Duncan’s, Tukey’s and Student-New-
man-Keuls’ multiple range tests. Non-linear concentration-response
data were ¢tted to several standard curves, and the best-¢tting curve
was selected for data transformation. Linear regression analysis was
then applied to the transformed data. All tests were run at P = 0.01.
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3. Results
3.1. Uptake of conjugates
The 125I thioether conjugate was taken up at 37‡C by
NG108-15 cells in a dose-dependent manner without satura-
tion (Fig. 1). The uptake was much lower at 4‡C or in the
presence of metabolic inhibitors. Each of the four curves in
Fig. 1 had a signi¢cantly positive slope. An X at a symbol
indicates that the corresponding mean is signi¢cantly di¡erent
from the control mean. We assume that the radioactivity as-
sociated with the cells at 4‡C re£ects largely the binding com-
ponent. The uptake could not be competitively inhibited with
non-conjugated (37^72)Tat. On the contrary, the addition of
non-labeled Tat resulted in an insigni¢cantly increased uptake
of the thioether conjugate. With Rev-2-T-6 cells, analogous
results were obtained (data not shown).
3.2. Intracellular localization of the conjugate
In chroma⁄n cells, the disul¢de conjugate labels both the
cytoplasm and the nucleus (Fig. 2) with £uorescence. In the
controls, auto£uorescence was virtually absent. A similar pat-
tern of £uorescence was found with the thioether conjugate,
but the nucleus showed less £uorescence (image not shown).
3.3. Restoration of stimulated exocytotic 3H release
The disul¢de conjugate restored the stimulated exocytotic
3H release from TET-intoxicated cells in a dose-dependent
manner. In Fig. 3, bar A shows the fractional stimulated
exocytotic 3H release (S3HR) from control cells (electropo-
rated in DMEM in the absence of TET), bar B shows the
S3HR from toxin cells (electroporated in DMEM containing
1 nM TET). The S3HR was signi¢cantly inhibited by TET
(compare bars A and B), but it was restored by the disul¢de
conjugate in a dose-dependent manner (bars B, C, D, E).
Because the S3HR were proportional data, their increase
was non-linear. For regression analysis, they were trans-
formed using the angular transformation. The slope of the
(linear) regression of the transformed data on log concentra-
tion was signi¢cantly di¡erent from zero. In addition, multiple
range tests disclosed that the mean response to each of the
three doses C, D, E was signi¢cantly di¡erent from the mean
control response B. In other controls, non-conjugated F(abP)2
had no signi¢cant e¡ect on intoxicated cells (compare bars B
and F) or on non-intoxicated cells (compare bars A and G),
and the disul¢de conjugate had no e¡ect on non-intoxicated
cells (compare bars A and H). In an additional control experi-
ment, tetanus toxin was reacted with disul¢de-linked Tat con-
jugate to form an immune complex, and the cells were sus-
pended in this solution and electroporated. Their transmitter
release was not impaired. This indicates that the neutralizing
immune reactivity of F(abP)2 as a part of the Tat conjugate
was not seriously reduced during the conjugate synthesis.
4. Discussion
The restoration of the stimulated 3H release by the disul¢de
conjugate con¢rms our working hypothesis and is the main
message of the present study. The uptake of the conjugates
resembles the uptake of the parent (37^72)Tat in that it is
energy-dependent [18]. This suggests an uptake by vesicular
endocytosis, although no evidence was found for a binding of
the thioether conjugate to high-a⁄nity receptors. Many natu-
ral protein toxins taken up by receptor-mediated endocytosis
and many synthesized conjugates with a biological e¡ect con-
tain a disul¢de that links the carrier domain with the e¡ector
domain. The disul¢de bridge is reduced inside the cell, where-
upon the e¡ector domain of the molecule leaves the vesicle
Fig. 1. Uptake and binding of a thioether conjugate of anti-tetanus
125I-F(abP)2 and (37^72)Tat by NG108-15 cells at 37‡C (¢lled
circles), in the presence of 10 WM (37^72)Tat (open circles), in the
presence of metabolic inhibitors (crossed circles), and at 4‡C (open
squares). Experimental conditions: n = 4 vessels per concentration,
60 min incubation time. An X at a data mean indicates a signi¢cant
di¡erence between this mean and the mean of the lowest concentra-
tion (3.25 nM).
Fig. 2. Detection of a disul¢de conjugate of Cy3-labeled F(abP)2
and (37^72)Tat in chroma⁄n cells. The cells were incubated with
the conjugate (100 nM) overnight. Beginning at the bottom of the
cells, confocal sections were acquired using 0.3 Wm steps. The image
is a maximum value projection of six sections (15^20).
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and exerts its action. The e¡ect of the protein on cellular
components is eliminated or weakened when the disul¢de
bridge is replaced with a thioether bridge (for instance, [23]).
Similarly in our experiments, the reducible disul¢de conjugate
restored the transmitter release of TET-intoxicated cells, while
the non-reducible thioether conjugate was ine⁄cient. This
lends further support to the hypothesis that a vesicular proc-
ess is involved in the uptake of the antibody-Tat conjugates. It
should be noted that the thioether (37^72)Tat-enzyme conju-
gates synthesized by Fawell et al. [15] were investigated for
activity on test substrates added to cell extracts, rather than
on physiological substrates in living cells. In general, disul¢de
conjugates are more promising than thioethers for the neu-
tralization of antigens in the cytoplasmic space. Concerning
the e⁄ciency of vesicular endocytosis for the translocation of
proteins into the neuronal cytoplasm, one should not be mis-
led by the extreme toxicity of clostridial toxins. In clostridial
and other toxins, the e¡ector domain of the protein acts as an
enzyme. Just a few molecules of this domain may therefore be
su⁄cient to hydrolyze proteins of the synaptobrevin/syntaxin/
SNAP25 fusion complex (SNARE) faster than they can be
synthesized. Therefore the low e⁄ciency of vesicular endocy-
tosis of the protein or of the translocation of its e¡ector do-
main may only result in a long latency between the applica-
tion of the toxin and the onset of the symptoms. In fact,
latencies of many days have been observed in vertebrates.
However, the low e⁄ciency of translocation of substances into
the cytoplasm by vesicular endocytosis may become a limiting
factor if the e¡ector domain acts only once. This happens with
conjugates containing antibodies, and may explain why, in
our experiments, a restoration of transmitter release from
TET-intoxicated cells by the disul¢de conjugate of (37^
72)Tat and anti-TET antibody could be observed only after
long incubation at elevated concentrations, and remained in-
complete. The conjugates between F(abP)2 and (37^72)Tat
prepared and characterized in the present study provide leader
pharmaceutical tools to study in vitro and in vivo the neuro-
protection against protein toxins.
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Fig. 3. A disul¢de conjugate of (37^72)TAT protein and anti-teta-
nus F(abP)2 reduces the inhibitory action of tetanus toxin on the
stimulated exocytotic fractional 3H release (S3HR) from bovine
chroma⁄n cells loaded with [3H]norepinephrine. Hatched columns:
cells electroporated in the presence of 1 nM TET. Open columns:
cells electroporated in the absence of TET. The S3HR of the control
cells (A) was decreased by TET (B, intoxicated cells) and restored
by the conjugate in a dose-dependent manner (21 nM in C, 81 nM
in D, 243 nM in E). An X at a data mean indicates a signi¢cant
di¡erence between this mean and the mean of B. 243 nM free
F(abP)2 had no signi¢cant in£uence on the S3HR of intoxicated cells
(compare B with F) and of control cells (compare A with G), and
243 nM conjugate had no e¡ect on its own on control cells (com-
pare A with H).
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